Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDER electronic review pilot study is under way, starting with bioequivalence data -- Woodcock at DIA.

Executive Summary

CDER ELECTRONIC REVIEW PILOT STUDY UNDER WAY for automated analysis of certain portions of drug applications. "We are looking at ways to do computer- assisted review of data sets using standardized tools," FDA Center for Drug Evaluation & Research Director Janet Woodcock, MD, reported at the annual Drug Information Association meeting in Montreal June 24. "This pilot is going very well," Woodcock said, but cautioned that "we need to go a long way on standardizing the data that is submitted before we can actually use it."
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030458

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel